1. affirm::DM
    Subject Demographics
  2. affirm::RAND
    Subject Randomization
  3. broom.helpers::supported_models
    Listing of Supported Models
  4. cards::ADAE
    Example ADaM Data
  5. cards::ADSL
    Example ADaM Data
  6. cards::ADTTE
    Example ADaM Data
  7. cards::ADAE
    Example ADaM Data
  8. cards::ADSL
    Example ADaM Data
  9. cards::ADTTE
    Example ADaM Data
  10. dcurves::df_binary
    Simulated data with a binary outcome
  11. dcurves::df_case_control
    Simulated data with a case-control outcome
  12. dcurves::df_surv
    Simulated data with a survival outcome
  13. ggsurvfit::adtte
    Example phase III clinical trial data set
  14. ggsurvfit::df_colon
    Formatted Copy of 'survival::colon'
  15. ggsurvfit::df_lung
    Formatted Copy of 'survival::lung'
  16. gtsummary::trial
    Results from a simulated study of two chemotherapy agents
  17. pharmaversesdtm::ae
    Adverse Events
  18. pharmaversesdtm::ae_ophtha
    Adverse Events for Ophthalmology
  19. pharmaversesdtm::ce_vaccine
    Clinical Events for Vaccine
  20. pharmaversesdtm::cm
    Concomitant Medication
  21. pharmaversesdtm::dm
    Demography
  22. pharmaversesdtm::dm_peds
    Demographic Dataset-pediatrics
  23. pharmaversesdtm::dm_vaccine
    Demographics for Vaccine
  24. pharmaversesdtm::ds
    Disposition
  25. pharmaversesdtm::eg
    Electrocardiogram
  26. pharmaversesdtm::ex
    Exposure
  27. pharmaversesdtm::ex_ophtha
    Exposure for Ophthalmology
  28. pharmaversesdtm::ex_vaccine
    Exposures for Vaccine
  29. pharmaversesdtm::face_vaccine
    Findings About Clinical Events for Vaccine
  30. pharmaversesdtm::is_vaccine
    Immunogenicity Specimen Assessments for Vaccine
  31. pharmaversesdtm::lb
    Laboratory Measurements
  32. pharmaversesdtm::mh
    Medical History
  33. pharmaversesdtm::oe_ophtha
    Ophthalmic Examinations for Ophthalmology
  34. pharmaversesdtm::pc
    Pharmacokinetic Concentrations
  35. pharmaversesdtm::pp
    Pharmacokinetic Parameters
  36. pharmaversesdtm::qs_ophtha
    Questionnaire for Ophthalmology
  37. pharmaversesdtm::rs_onco
    Disease Response for Oncology
  38. pharmaversesdtm::rs_onco_ca125
    Disease Response (GCIG)
  39. pharmaversesdtm::rs_onco_imwg
    Disease Response (IMWG)
  40. pharmaversesdtm::rs_onco_irecist
    Disease Response (iRECIST) for Oncology
  41. pharmaversesdtm::rs_onco_recist
    Disease Response (RECIST 1.1) for Oncology
  42. pharmaversesdtm::sc_ophtha
    Subject Characteristic for Ophthalmology
  43. pharmaversesdtm::sdg_db
    SDG
  44. pharmaversesdtm::smq_db
    Standardized MedDRA Queries
  45. pharmaversesdtm::suppae
    Supplemental Adverse Events
  46. pharmaversesdtm::suppce_vaccine
    Supplemental Qualifiers for Clinical Events for Vaccine
  47. pharmaversesdtm::suppdm
    Supplemental Demography
  48. pharmaversesdtm::suppdm_vaccine
    Supplemental Qualifiers for Demographics for Vaccine
  49. pharmaversesdtm::suppds
    Supplemental Disposition
  50. pharmaversesdtm::suppex_vaccine
    Supplemental Qualifiers for Exposures for Vaccine
  51. pharmaversesdtm::suppface_vaccine
    Supplemental Qualifiers for Findings About for Clinical Events for Vaccine
  52. pharmaversesdtm::suppis_vaccine
    Supplemental Qualifiers for Immunogenicity Specimen Assessments for Vaccine
  53. pharmaversesdtm::supprs_onco_ca125
    Supplemental Qualifiers for RS_ONCO_CA125
  54. pharmaversesdtm::supprs_onco_imwg
    Supplemental Qualifiers for RS_ONCO_IMWG
  55. pharmaversesdtm::supptr_onco
    Supplemental Tumor Results for Oncology
  56. pharmaversesdtm::sv
    Subject Visits
  57. pharmaversesdtm::tr_onco
    Tumor Results for Oncology
  58. pharmaversesdtm::tr_onco_recist
    Tumor Results (RECIST 1.1) for Oncology
  59. pharmaversesdtm::ts
    Trial Design
  60. pharmaversesdtm::tu_onco
    Tumor Identification for Oncology
  61. pharmaversesdtm::tu_onco_recist
    Tumor Identification (RECIST 1.1) for Oncology
  62. pharmaversesdtm::vs
    Vital Signs
  63. pharmaversesdtm::vs_peds
    Vital signs Dataset-pediatrics
  64. pharmaversesdtm::vs_vaccine
    Vital Signs for Vaccine
  65. starter::project_templates
    Project templates
  66. tfrmt::data_ae
    Adverse Events Analysis Results Data
  67. tfrmt::data_demog
    Demography Analysis Results Data
  68. tfrmt::data_efficacy
    Efficacy Analysis Results Data
  69. tfrmt::data_labs
    Labs Analysis Results Data
  70. tidycmprsk::trial
    Results from a simulated study of two chemotherapy agents
  71. tidycmprsk::trial
    Results from a simulated study of two chemotherapy agents